The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Canixin L suspension for injection for dogs

. Suspension for injection

Virbac S.A.VPA10988/102/001

Main Information

Trade NameCanixin L suspension for injection for dogs
Active SubstancesLeptospira interrogans serogroup icterohaemorragiae, inactivated
Leptospira interrogans serogroup canicola, inactivated
Dosage FormSuspension for injection
Licence HolderVirbac S.A.
Licence NumberVPA10988/102/001

Group Information

ATC CodeQI07AB01 leptospira
Therapeutic ClassImmunological - Inactivated Vaccine


Licence Issued24/03/2017
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back